MarketPeel
Insider Trading Intelligence
DO

David Owens

NXL
CHIEF MEDICAL OFFICER · NEXALIN TECHNOLOGY, INC. · CIK 0001916664
FILING MIX · LIFETIME100%/0%
BUYS
20
SELLS
0
TOTAL VALUE
$36.1K
COMPANIES
1
ACTIVE SINCE
Sep 2022
HOLDINGS NOW
2,484,809
AVG SELL PX
TRADE KIND
SHOWING 20 / 20
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 7 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by David Owens, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+90.91%+19.06%+0.97%+18.09%+11.54%
14d11+81.82%+61.52%+1.74%+59.78%+31.39%
30d11+63.64%+26.34%+0.63%+25.71%+11.99%
60d11+27.27%-8.18%-3.08%-5.09%-11.15%
90d11+36.36%+0.84%-1.11%+1.95%-20.77%
180d11+45.45%+126.06%+7.79%+118.27%-12.23%
1y11+27.27%-26.61%+15.34%-41.95%-59.62%
2y11(7 pending)+0.00%-51.21%+36.06%-87.27%-83.36%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NXL · 2,484,809 shares · as of Dec 19, 2025
0621,2021,242,4051,863,6072,484,809202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 20 buys / 0 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
1,000,0002,484,809Dec 19, 2025Dec 23, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
36,459191,252Sep 29, 2025Sep 30, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
203,1251,384,809Sep 12, 2025Sep 12, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
100,0001,484,809Sep 12, 2025Sep 12, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
125,000919,184Feb 26, 2025Feb 27, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
654,363794,184Feb 26, 2025Feb 27, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
139,821139,821Feb 26, 2025Feb 27, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
1,000$2.98$3.0K154,793Feb 4, 2025Feb 4, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
1,000$3.10$3.1K155,793Feb 4, 2025Feb 5, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
1,500$2.70$4.0K153,793Jan 28, 2025Jan 29, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
1,000$2.70$2.7K152,293Jan 23, 2025Jan 24, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
2,000$2.50$5.0K151,293Jan 13, 2025Jan 24, 2025View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
500$2.19$1.1K148,293Oct 28, 2024Oct 30, 2024View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
1,000$0.95$950147,793Aug 13, 2024Aug 15, 2024View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
1,000$1.75$1.8K146,793Jun 28, 2024Jul 1, 2024View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
1,619$0.71$1.1K145,793Jun 18, 2024Jun 21, 2024View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
1,000$0.62$620144,174Jun 10, 2024Jun 12, 2024View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
2,000$0.65$1.3K143,174Jun 10, 2024Jun 12, 2024View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
2,500$0.40$1.0K2,500Sep 16, 2022Oct 5, 2023View →
NXL
NEXALIN TECHNOLOGY, INC.
PURCHASE
Chief Medical Officer
2,500$4.15$10.4K141,174Sep 16, 2022Sep 20, 2022View →
Other insiders · NXL
Loading peer insiders…
About this filer
CIK 0001916664
ROLE
Chief Medical Officer
PRIMARY
NXL
COMPANIES
1
ACTIVE SINCE
Sep 2022
MARKETPEEL · /INSIDER/0001916664DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback